Search clinical trials for: d-Amphetamine; Atomoxetine

Total 4566 results

University Hospital, Basel, Switzerland

Completed

Endocrine and Emotional Effects of Lisdexamfetamine and d-Amphetamine. (LisDex)

Healthy

Switzerland
University of Kentucky
National Institute on Drug Abuse (NIDA)

Completed

Agonist Replacement Therapy for Cocaine Dependence

Cocaine Dependence

United States
University of Illinois at Chicago
The University of Texas Health Science Center, Houston

Recruiting

Targeting Anhedonia in Cocaine Use Disorder

Anhedonia | Cocaine-Related Disorders

United States
Shire

Completed

Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD

ADHD

United States
Shire

Completed

Safety and Efficacy of SPD465 in Adults With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Shire

Completed

Efficacy and Safety of SPD465 in Adults With ADHD

Attention Deficit Disorder With Hyperactivity
The University of Texas Health Science Center,...
Emory University

Completed

Effect of D-amphetamine on Reward Functioning

Anhedonia

United States
Shire

Completed

Safety of SPD465 in Treating Adults With ADHD.

Attention Deficit Disorder With Hyperactivity
Shire

Completed

ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Noven Pharmaceuticals, Inc.

Completed

Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System vs Placebo in Children & Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

United States
Shire

Completed

Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.

Attention Deficit Disorder With Hyperactivity
University of California, Irvine

Completed

The Reinforcing Mechanisms of Smoking in Adult ADHD

ADHD

United States
University of Chicago

Completed

Differential Responses to Drugs and Sweet Tastes (HAP)

Bipolar II Disorder

United States
Janssen-Cilag International NV

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male Participants

Healthy

Netherlands
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
Mayo Clinic
Lindner Center of HOPE

Recruiting

8 Week Multi-site Study of MYDAYIS® for Bipolar Depression

Bipolar Depression

United States
Janssen Research & Development, LLC

Completed

A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

Attention Deficit Disorder With Hyperactivity

United States
Massachusetts General Hospital

Completed

Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits

Attention Deficit Hyperactivity Disorder (ADHD) | Deficient Emotional Self-Regulation (DESR)

United States
The University of Texas Health Science Center,...
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Interventions for Children With Attention and Reading Disorders (ICARD)

Attention Deficit Hyperactivity Disorder | Reading Disabilities

United States
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals

Cocaine-Related Disorders

United States
Rajesh Narendran
National Institute on Drug Abuse (NIDA)

Recruiting

[C-11]NPA PET-amphetamine in Cocaine Use Disorders

Cocaine Use Disorder

United States
Duke University

Completed

Amphetamine-Enhanced Stroke Recovery

Stroke

United States
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Atomoxetine

Obesity, Morbid

Norway
Eli Lilly and Company

Completed

A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Spain, France, Austria, Germany, Belgium, Finland, Italy, Netherlands, Portugal, Sweden, Switzerland, United Kingdom
Eli Lilly and Company

Completed

An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).

Attention Deficit Hyperactivity Disorder | Oppositional Defiant Disorder

Italy
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Dextroamphetamine as an Adjunct in Cocaine Treatment - 1

Substance-Related Disorders | Cocaine-Related Disorders

United States
University of California, San Diego

Completed

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

Schizophrenia

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Dextroamphetamine-Cocaine Behavioral Intervention - 5

Cocaine-Related Disorders

United States
Gale Richardson
National Institute on Drug Abuse (NIDA)

Completed

Brain Mechanisms in Young Adults (MHP)

Cocaine-Related Disorders

United States
Vallon Pharmaceuticals, Inc.

Completed

Pilot Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR)

ADHD | Narcolepsy

Canada
Joshua A. Lile, Ph.D.
National Institute on Drug Abuse (NIDA)

Recruiting

Neurobehavioral Mechanisms of Cocaine Choice

Cocaine Use Disorder

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Terminated

Safety Assessment of Atomoxetine With MA IV Administration

Methamphetamine Dependence | Methamphetamine Abuse

United States
Biotie Therapies Inc.
Acorda Therapeutics

Terminated

A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users

Abuse Potential

Canada
Brigham and Women's Hospital

Not yet recruiting

Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea

OSA

United States
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression (Ammoxetine)

Major Depressive Disorder (MDD)
University of Pittsburgh
National Institute on Drug Abuse (NIDA)

Completed

Cocaine Use Disorder and Cortical Dopamine

Cocaine Dependence

United States
Vallon Pharmaceuticals, Inc.

Completed

Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR) (SEAL)

ADHD | Narcolepsy

United States
Stephen Robert Marder

Not yet recruiting

MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

Post Traumatic Stress Disorder

United States
Tris Pharma, Inc.

Completed

Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years

Attention Deficit Hyperactivity Disorder

United States
Poitiers University Hospital

Terminated

Atomoxetine in Patients With Tourette's Syndrome (ATO-TS)

Tourette Syndrome

France
NYU Langone Health
Eli Lilly and Company

Completed

Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility

Attention Deficit Hyperactivity Disorder
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Atomoxetine Effects in Humans

Physiological Stress
Peking University

Unknown

Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

China
Central Institute of Mental Health, Mannheim
Heidelberg University

Completed

Driving in Adults With Attention-deficit/Hyperactivity Disorder (ADHD) Before and During Treatment With Atomoxetine (DrivPerfATX)

Attention Deficit Hyperactivity Disorder

Germany
Eli Lilly and Company

Completed

An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Germany
Eli Lilly and Company

Completed

An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Germany
Eli Lilly and Company

Completed

Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD

Attention-Deficit/Hyperactivity Disorder

United States
Rhode Island Hospital
Eli Lilly and Company

Unknown

Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents

Insomnia | Attention-Deficit/Hyperactivity Disorder (ADHD)

United States
Lindner Center of HOPE
University of Cincinnati

Completed

Atomoxetine in the Treatment of Binge Eating Disorder

Binge-eating Disorder

United States
Joshua A. Lile, Ph.D.

Completed

Impact of Sustained Release d-Amphetamine on Choice Between Cocaine and a Non-Drug Reinforcer

Active Cocaine Users

United States

Search clinical trials for: d-Amphetamine; Atomoxetine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations